CollPlant Biotechnologies Ltd. (CLGN) reported its first quarter 2025 financial results and provided a comprehensive corporate update highlighting progress across its regenerative and aesthetic medicine pipeline.
The Israel-based company develops tissue regeneration and aesthetic products using its proprietary, non-animal recombinant human collagen or rhCollagen. Its platform supports applications in breast implants, dermal fillers, and bioinks for 3D bioprinting.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.